W. Rose

发表

AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY

W. Rose, 2003 .

Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.

S. Forenza, W. Rose, B. Long, 2002, Current medicinal chemistry. Anti-cancer agents.

Korkormicins, novel depsipeptide antitumor antibiotics fromMicromonospora sp C39500: Fermentation, precursor directed biosynthesis and biological activities

G. Hesler, S. Forenza, K. S. Lam, 1995, Journal of Industrial Microbiology.

Synthesis and in vivo antitumor activity of novel mitomycin A disulfide analogs.

T. Doyle, W. Rose, W. T. Bradner, 1989, The Journal of antibiotics.

ANTITUMOR ACTIVITY OF PLATINUM ANALOGS

W. Rose, W. T. Bradner, J. Huftalen, 1980 .

Novel strategies for the discovery of plant-derived anticancer agents

G. Cordell, J. Pezzuto, C. Fairchild, 1994 .

Experimental studies on creatine and creatinine

W. Rose, 1911 .

EXPERIMENTAL STUDIES ON CREATINE AND CREATININE VII. THE FATE OF CREATINE AND CREATININE WHEN ADMINISTERED TO MAN

W. Rose, F. W. Dimmitt, 1916 .

The Metabolism of Creatine and Creatinine

W. Rose, 1933 .

Preclinical pharmacology of BMS-275183, an orally active taxane.

C. Fairchild, J. Kadow, F. Lee, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A MODIFIED METHOD FOR THE ESTIMATION OF TOTAL CREATININE IN SMALL AMOUNTS OF TISSUES

W. Rose, A. Chanutin, O. M. Helmer, 1927 .

THE TRANSFORMATION OF CREATINE INTO CREATININE BY THE MALE AND FEMALE HUMAN ORGANISM

W. Rose, R. Ellis, O. Helming, 1928 .

Interaction of bacterial toxins in the toxicity of chemotherapeutic agents.

W. Rose, William C. Rose, 1973, CRC critical reviews in toxicology.

Synthesis and antitumor evaluation of 2′-oxycarbonylpaclitaxels (paclitaxel-2′-carbonates)

C. Fairchild, W. Rose, E. Kerns, 1994 .

Preclinical antitumor and toxicologic profile of carboplatin.

W. Rose, J. Schurig, William C. Rose, 1985, Cancer treatment reviews.

THE NUTRITIVE SIGNIFICANCE OF THE AMINO ACIDS

W. Rose, 1938 .

The partial replacement of dietary phenylalanine by tyrosine for purposes of growth.

W. Rose, M. Womack, 1946, The Journal of biological chemistry.

Feeding experiments with mixtures of highly purified amino acids. 6. The relation of phenylalanine and tyrosine to growth.

W. Rose, M. Womack, 1934 .

AMINO ACID REQUIREMENTS OF MAN

W. Rose, 2009 .

Nutrition Classics. Federation Proceedings 8(2)546-52, June 1949. Amino acid requirements of man. William C. Rose.

W. Rose, 1976, Nutrition reviews.

TAXOL STRUCTURE-ACTIVITY RELATIONSHIPS : SYNTHESIS AND BIOLOGICAL EVALUATION OF TAXOL ANALOGS MODIFIED AT C-7

Jianmei Wei, G. Roth, C. Fairchild, 1994 .

Prolonged survival of AKR mice following allogeneic bone marrow transplantation

E. Saltzstein, W. Rose, M. Bortin, 1974, Experientia.

Preclinical efficacy evaluation of ixabepilone (BMS-247550) in combination with cetuximab or capecitabine in human colon and lung carcinoma xenografts.

F. Lee, D. Kan, W. Rose, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antitumor activity and toxicity of cisplatin analogs.

W. Rose, W. T. Bradner, J. Schurig, 1982, Cancer treatment reports.

The amino acid requirements of man. VI. The rôle of the caloric intake.

M. J. Coon, W. Rose, G. Lambert, 1954, The Journal of biological chemistry.

Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.

J. Catino, W. Rose, W. T. Bradner, 1985, Cancer research.

The role of the amino acids in human nutrition.

W. Rose, 1942, Proceedings of the American Philosophical Society.

Structure-activity relationships study at the 3′-N position of paclitaxel-part 1: Synthesis and biological evaluation of the 3′-(t)-butylaminocarbonyloxy bearing paclitaxel analogs

Stella Huang, C. Fairchild, J. Kadow, 1997 .

TRANSPLANTATION OF HEMATOPOIETIC AND LYMPHOID CELLS IN MICE: H‐2 MATCHED UNRELATED ADULT DONORS COMPARED WITH H‐2 MISMATCHED FETAL DONORS

A. Rimm, R. Truitt, E. Saltzstein, 1976, Transplantation.

Experimental Antitumor Activity of Platinum Coordination Complexes

W. Rose, W. T. Bradner, 1984 .

Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.

A. Rimm, R. Truitt, E. Saltzstein, 1975, Journal of the National Cancer Institute.

Synthesis and antitumor evaluation of paclitaxel phosphonooxymethyl ethers: a novel class of water soluble paclitaxel pro-drugs

T. Doyle, W. Rose, J. Knipe, 1996 .

The amino acid requirements of man. 1. The role of valine and methionine.

W. Rose, Julius E. Johnson, W. J. Haines, 1950 .

Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476.

C. Fairchild, J. Kadow, F. Lee, 2001, Journal of medicinal chemistry.

Preclinical antitumor activity of two novel taxanes

F. Lee, C. Fairchild, W. Rose, 2000, Cancer Chemotherapy and Pharmacology.

Urea as a source of nitrogen for the biosynthesis of amino acids.

W. Rose, E. E. Dekker, 1956, The Journal of biological chemistry.

Novel water soluble phosphate prodrugs of taxol® possessing in vivo antitumor activity

W. Rose, J. Knipe, A. Casazza, 1993 .

Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

G. Cordell, J. Pezzuto, A. Kinghorn, 2004, The Journal of organic chemistry.

Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.

M. Barbacid, B. Seizinger, J. Hunt, 1996, Journal of medicinal chemistry.

The amino acid requirements of man. XVI. The role of the nitrogen intake.

W. Rose, R. L. Wixom, 1955, The Journal of biological chemistry.

The utilization of the nitrogen of ammonium salts, urea, and certain other compounds in the synthesis of non-essential amino acids in vivo.

W. Rose, L. C. Smith, 1949, The Journal of biological chemistry.

In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues.

J. C. Martin, W. Rose, J. Bronson, 1990, Journal of the National Cancer Institute.

Discovery of anticancer agents of diverse natural origin

A. Kinghorn, D. Jarjoura, S. Emanuel, 2009, Pure and applied chemistry. Chimie pure et appliquee.

The amino acid requirements of man. IX. The phenylalanine requirement.

M. J. Coon, W. Rose, G. Lambert, 1955, The Journal of biological chemistry.

THE AVAILABILITY OF SYNTHETIC IMIDAZOLES IN SUPPLEMENTING DIETS DEFICIENT IN HISTIDINE

W. Rose, G. J. Cox, 1926 .

II. The sequence of events leading to the establishment of the amino acid needs of man.

W. Rose, 1968, American journal of public health and the nation's health.

THE RELATION OF ARGININE AND HISTIDINE TO GROWTH

W. Rose, G. J. Cox, 1924 .

The role of proline, hydroxyproline, and glutamic acid in growth.

W. Rose, M. Womack, 1947 .

THE SIGNIFICANCE OF THE AMINO ACIDS IN CANINE NUTRITION.

W. Rose, E. E. Rice, 1939, Science.

Isolation of the "unknown essential" present in proteins.

Herbert E. Carter, E. Mertz, W. Rose, 1935 .

Taxol®: science and applications.

Michael L. Shuler, Haeil Park, William C. Rose, 1995 .

Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.

D. Langley, C. Fairchild, R. Kramer, 2005, Journal of medicinal chemistry.

Design and Synthesis of a Fluoroindolocarbazole Series as Selective Topoisomerase I Active Agents. Discovery of Water-Soluble 3,9-Difluoro-12,13-dihydro-13-[6-amino-β- d-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with Curative Antitumor Activit

C. Fairchild, M. Deshpande, R. Kramer, 2004 .

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.

A. Sartorelli, K. Vasquez, R. Finch, 2000, Biochemical pharmacology.

Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.

W. Rose, J. Ambrus, M. Perlman, 1985, Journal of medicinal chemistry.

Bicyclic and tricyclic analogues of anthramycin.

T. Doyle, T. Kaneko, W. Rose, 1985, Journal of medicinal chemistry.

Bicyclic and tricyclic analogs of anthramycin

T. Doyle, T. Kaneko, W. Rose, 1985 .

Synthesis and biological activity of modified enediyne chemotypes

G. Roth, J. Kadow, W. Rose, 1994 .

THE SPATIAL CONFIGURATION OF α-AMINO-β-HYDROXY-n-BUTYRIC ACID

W. Rose, C. E. Meyer, 1936 .

THE UTILIZATION OF CERTAIN SULFUR-CONTAINING COMPOUNDS FOR GROWTH PURPOSES

W. Rose, E. E. Rice, 1939 .

Eupenifeldin, a novel cytotoxic bistropolone from Eupenicillium brefeldianum.

D. Pirnik, S. Klohr, S. Huang, 1993, The Journal of antibiotics.

Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels

F. Luo, S. Castaneda, I. Inigo, 2006, Molecular Cancer Therapeutics.

Enhanced Toxicity for Mice of Combinations of Antibiotics with Escherichia coli Cells or Salmonella typhosa Endotoxin

S. Bradley, W. Rose, 1971, Infection and immunity.

The amino acid requirements of man. XIII. The sparing effect of cystine on the methionine requirement.

W. Rose, R. L. Wixom, 1955, The Journal of biological chemistry.

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

F. Lee, Soong-Hoon Kim, C. Fairchild, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

The amino acid requirements of man. XIV. The sparing effect of tyrosine on the phenylalanine requirement.

W. Rose, R. L. Wixom, 1955, The Journal of biological chemistry.

Erratum: Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris (Journal of Organic Chemistry (2004) 69 (3350-3357))

G. Cordell, J. Pezzuto, A. Kinghorn, 2004 .

Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

G. Cordell, J. Pezzuto, A. Kinghorn, 2004, The Journal of organic chemistry.

Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice.

A. Rimm, R. Truitt, E. Saltzstein, 1976, Advances in experimental medicine and biology.

THE METABOLISM OF VALINE IN PHLORHIZIN GLYCOSURIA

W. Rose, Julius E. Johnson, W. J. Haines, 1942 .

THE IN VIVO CONVERSION OF GLUTAMIC ACID INTO PROLINE AND ARGININE1

R. Koeppe, W. Rose, H. J. Sallach, 1951 .

Synthesis and biological activity of A-nor-paclitaxel analogues.

D. Kingston, M. Chordia, E. Hamel, 1997, Bioorganic & medicinal chemistry.

Methionine requirement for growth and utilization of its optical isomers.

W. Rose, K. A. J. Wretlind, 1950, The Journal of biological chemistry.

Synthesis of new nucleoside phosphoraziridines as potential site-directed antineoplastic agents.

W. Rose, J. A. Dunn, T. Bardos, 1990, Journal of medicinal chemistry.

Synthesis of New Nucleoside Phosphoraziridines as Potential Site- Directed Antineoplastic Agents.

W. Rose, J. A. Dunn, T. Bardos, 1991 .

Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.

G. Wampler, W. Rose, J. A. Dunn, 1991, Journal of Medicinal Chemistry.

THE RELATION OF HISTIDINE AND ARGININE TO CREATINE AND PURINE METABOLISM

W. Rose, K. Cook, 1925 .

Cytotoxic prenylated xanthones and the unusual compounds anthraquinobenzophenones from Cratoxylum sumatranum.

A. Kinghorn, C. Fairchild, H. Navarro, 2002, Journal of natural products.

Reductive amination of 3-ketoanguidin and antitumor activity of the products.

T. Doyle, H. G. Howell, W. Rose, 1985, Journal of medicinal chemistry.

Structural modifications of anguidin and antitumor activities of its analogues.

T. Doyle, H. G. Howell, J. Davies, 1982, Journal of medicinal chemistry.

Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.

S. Chong, J. Hunt, Soong-Hoon Kim, 2000, Journal of medicinal chemistry.

CAN PURINES, CREATININE, OR CREATINE REPLACE HISTIDINE IN THE DIET FOR PURPOSES OF GROWTH?

W. Rose, G. J. Cox, 1926 .

Experimental antitumor activity of BMY-28090, a new antitumor antibiotic

W. Rose, W. T. Bradner, J. Schurig, 1989, Investigational New Drugs.

Production, isolation and structure determination of novel fluoroindolocarbazoles from Saccharothrix aerocolonigenes ATCC 39243.

S. Forenza, K. S. Lam, T. Doyle, 2001, The Journal of antibiotics.

Antitumor activity of chrysomycins M and V.

T. Doyle, J. Bush, W. Rose, 1989, The Journal of antibiotics.

"Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impact.

G. Tan, J. Pezzuto, S. Franzblau, 2006, Journal of natural products.

Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.

W. Rose, W. T. Bradner, P. Siminoff, 1984, Cancer research.

Taxol: a review of its preclinical in vivo antitumor activity.

W. Rose, 1992, Anti-cancer drugs.

Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.

F. Lee, V. Manne, M. Lynch, 2001, Cancer research.

Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization

P. Marathe, C. Fairchild, T. Monticello, 2006, Cancer Chemotherapy and Pharmacology.

Potentiation of the toxicity of several antitumor agents by Salmonella typhosa endotoxin.

S. Bradley, W. Rose, I. Lee, 1972, Toxicology and applied pharmacology.

Enhanced Toxicity for Mice of Vincristine and Other Chemotherapeutic Agents with Salmonella typhosa Endotoxin and Pseudomonas aeruginosa

S. Bradley, W. Rose, I. Lee, 1972, Antimicrobial Agents and Chemotherapy.

THE NUTRITIVE SIGNIFICANCE OF THE AMINO ACIDS AND CERTAIN RELATED COMPOUNDS.

W. Rose, 1937, Science.

The amino acid requirements of man. IV. The rôle of leucine and phenylalanine.

W. Rose, D. Warner, W. J. Haines, 1951, The Journal of biological chemistry.

The amino acid requirements of man. V. The rôle of lysine, arginine, and tryptophan.

W. Rose, D. Warner, W. J. Haines, 1954, The Journal of biological chemistry.

BIOCHEMICAL STUDIES ON MARINE ORGANISMS

W. Rose, M. Bodansky, 1920 .

BIOCHEMICAL STUDIES ON MARINE ORGANISMS I. THE OCCURRENCE OF COPPER

W. Rose, M. Bodansky, 1920 .

Synthesis and Antitumor Evaluation of 2′-Oxycarbonylpaclitaxels ( Paclitaxel-2′-carbonates).

C. Fairchild, W. Rose, E. Kerns, 1995 .

EXPERIMENTAL STUDIES ON CREATINE AND CREATININE III. EXCRETION OF CREATINE IN INFANCY AND CHILDHOOD

W. Rose, 1911 .

EXPERIMENTAL STUDIES ON CREATINE AND CREATININE VI. PROTEIN FEEDING AND CREATINE ELIMINATION IN FASTING MAN

W. Rose, F. W. Dimmitt, P. Cheatham, 1916 .

STUDIES IN THE PURINE METABOLISM I. ON URICOLYSIS IN THE HUMAN SUBJECT

W. Rose, A. Taylor, 1913 .

EXPERIMENTAL STUDIES ON CREATINE AND CREATININE I. THE RÔLE OF THE CARBOHYDRATES IN CREATINE-CREATININE METABOLISM

W. Rose, L. Mendel, 1911 .

The amino acid requirements of man. III. The rôle of isoleucine; additional evidence concerning histidine.

W. Rose, D. Warner, W. J. Haines, 1951 .

COMPARATIVE STUDIES OF DIGESTION

W. Rose, M. Bodansky, 1922 .

The partial replacement of dietary methionine by cystine for pur poses of growth.

W. Rose, M. Womack, 1941 .

Development of Farnesyltransferase Inhibitors as Potential Antitumor Agents

F. Lee, V. Manne, C. Fairchild, 2001 .

Growth of human tumors in lethally irradiated mice reconstituted with syngeneic fetal liver cells

A. Rimm, R. Truitt, E. Saltzstein, 1977, Cancer.

GRAFT‐VERSUS‐LEUKEMIA: V. ABSENCE OF ANTILEUKEMIC EFFECT USING ALLOGENEIC H‐2‐IDENTICAL IMMUNOCOMPETENT CELLS

A. Rimm, W. Rose, M. Bortin, 1974, Transplantation.

Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors.

F. Schabel, W. Rose, W. R. Laster, 1979, Cancer treatment reports.

EUPENIFELDIN, A NOVEL CYTOTOXIC BISTROPOLONE FROM

Steven, Donald, Huang, 2006 .

Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids.

J. Kadow, K. Johnston, W. Rose, 2001, Bioorganic & medicinal chemistry letters.

Structure-activity relationships study at the 3'-N position of paclitaxel. Part 2: synthesis and biological evaluation of 3'-N-thiourea- and 3'-N-thiocarbamate-bearing paclitaxel analogues.

C. Fairchild, J. Kadow, K. Johnston, 2000, Bioorganic & medicinal chemistry letters.

NOVEL C-4 PACLITAXEL (TAXOL) ANALOGS : POTENT ANTITUMOR AGENTS

Jianmei Wei, C. Fairchild, J. Kadow, 1995 .

THE SYNTHESIS AND BIOLOGICAL ACTIVITY OF ENEDIYNE MINOR GROOVE BINDING HYBRIDS

D. Langley, J. Kadow, W. Rose, 1995 .

The effect of propargylic substitution on the activation and aromatization of enediynes

J. Kadow, W. Rose, M. Wittman, 1994 .

Synthesis and antileukemic activity of etoposide a-ring analogs

J. Kadow, T. Doyle, W. Rose, 1992 .

Comparative growth on diets containing ten and 19 amino acids, with further observations upon the role of glutamic and aspartic acids.

W. Rose, M. Oesterling, M. Womack, 1948, The Journal of biological chemistry.

The amino acid requirements of man. II. The role of threonine and histidine.

W. Rose, D. Warner, J. E. Johnson, 1951, The Journal of biological chemistry.

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft

F. Lee, R. Kramer, F. Luo, 2005, Cancer Chemotherapy and Pharmacology.

Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.

S. Crooke, W. Rose, W. T. Bradner, 1979, Cancer treatment reports.

The amino acid requirements of man. XV. The valine requirement; summary and final observations.

W. Rose, R. L. Wixom, H. B. Lockhart, 1955, The Journal of biological chemistry.

Preclinical antitumor activity of orally administered platinum (IV) complexes

W. Rose, A. Casazza, J. Schurig, 2004, Cancer Chemotherapy and Pharmacology.

Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent

W. Rose, W. T. Bradner, H. Kamei, 1990, Investigational new drugs.

Graft-versus-Leukemia, Donor Selection for Adoptive Immunotherapy in Mice

R. Truitt, W. Rose, M. Bortin, 1977 .

Synthesis and biological activity of macrocyclic taxane analogues.

James G. Tarrant, C. Fairchild, J. Kadow, 2004, Bioorganic & medicinal chemistry letters.

The relation of cystine and methionine to growth.

W. Rose, K. S. Kemmerer, M. Womack, 1937 .

Evaluation of platinol analogs using the M5076 murine sarcoma.

W. Rose, 1986, Anticancer research.

Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.

W. Rose, W. T. Bradner, J. Schurig, 1983, Cancer research.

Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs.

W. Rose, 1981, Cancer treatment reports.

Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.

W. Rose, W. T. Bradner, J. Schurig, 1984, Cancer research.

Ethnobotany/ethnopharmacology and mass bioprospecting: issues on intellectual property and benefit-sharing.

Tran Van Thuy, H H S Fong, N T Hiep, 2005, Journal of ethnopharmacology.

Preclinical antitumor activity of water-soluble paclitaxel derivatives

F. Lee, W. Rose, A. Casazza, 1997, Cancer Chemotherapy and Pharmacology.

EXPERIMENTS ON THE NUTRITIVE PROPERTIES OF GELATIN

W. Rose, R. W. Jackson, Beatrice E. Sommer, 1928 .

Combination chemotherapy involving orally administered etoposide and JM-216 in murine tumor models

W. Rose, 1997, Cancer Chemotherapy and Pharmacology.

Production and isolation of two novel esperamicins in a chemically defined medium.

J. Veitch, S. Forenza, K. S. Lam, 1995, The Journal of antibiotics.

Enhanced Toxicity for Mice of Pactamycin with Bacterial Endotoxin

S. Bradley, W. Rose, 1973, Antimicrobial Agents and Chemotherapy.

Retardation by Methylprednisolone of the Synergistic Toxicity of Endotoxin with Sparsomycin or Pactamycin 1

S. Bradley, W. Rose, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Therapeutic Synergy of Oral Taxane BMS-275183 and Cetuximab versus Human Tumor Xenografts

W. Rose, R. Wild, 2004, Clinical Cancer Research.

The amino acid requirements of man. X. The lysine requirement.

M. J. Coon, W. Rose, G. Lambert, 1955, Journal of Biological Chemistry.

The amino acid requirements of man. VII. General procedures; the tryptophan requirement.

M. J. Coon, W. Rose, G. Lambert, 1954, The Journal of biological chemistry.

The relation of aspartic acid and glucosamine to growth.

W. Rose, S. S. Fierke, 1942 .

THE SYNTHESIS OF CYSTINE IN VIVO

W. Rose, T. R. Wood, 1941 .

EXPERIMENTAL STUDIES ON CREATINE AND CREATININE II. INANITION AND THE CREATINE CONTENT OF MUSCLE

W. Rose, L. Mendel, 1911 .

THE INFLUENCE OF FOOD INGESTION UPON ENDOGENOUS PURINE METABOLISM. II

W. Rose, H. Bartlett, 1921 .

The relation of leucine, isoleucine and norleucine to growth.

W. Rose, M. Womack, 1936 .

Feeding experiments with mixtures of highly purified amino acids. 7. The dual nature of the "unknown growth essential.".

W. Rose, M. Womack, 1935 .

THE AMINO ACID REQUIREMENTS OF MAN THE

Haines, W. Rose, Johnson, 2003 .

THE INFLUENCE OF PROTEIN INTAKE UPON THE FORMATION OF URIC ACID

A. Taylor, W. Rose, 1914 .

COMPARATIVE STUDIES OF DIGESTION: I. The Digestive Enzymes of Coelenterates

W. Rose, M. Bodansky, 1922 .

ARGININE METABOLISM I. THE RELATION OF THE ARGININE CONTENT OF THE DIET TO THE INCREMENTS IN TISSUE ARGININE DURING GROWTH

W. Rose, C. Scull, 1930 .

EXPERIMENTAL STUDIES ON CREATINE AND CREATININE V. PROTEIN FEEDING AND CREATINE ELIMINATION IN PANCREATIC DIABETES

W. Rose, 1916 .

Novel, water-soluble phosphate derivatives of 2′-ethoxy carbonylpaclitaxel as potential prodrugs of paclitaxel: Synthesis and antitumor evaluation

W. Rose, J. Knipe, V. Farina, 1995 .

New Anticancer Drugs from Cultured and Collected Marine Organisms

Eric J. Kantorowski, Y. Shimizu, C. Fairchild, 2003 .

The discovery of BMS-275183: an orally efficacious novel taxane.

James G. Tarrant, C. Fairchild, J. Kadow, 2003, Bioorganic & medicinal chemistry.

Studies on dynemicin. A nonradical cycloaromatization pathway for the azabicyclo[7.3.1] enediyne core structure initiated by thiolate addition

W. Rose, P. Magnus, S. Eisenbeis, 1993 .

In vivo evaluation of epidermal growth factor and transforming growth factor β 1 in mouse tumor models

S. Robinson, W. Rose, A. Casazza, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Rôle of alimentary microorganisms in the synthesis of non-essential amino acids.

W. Rose, L. C. Smith, 1950, Journal of Biological Chemistry.

Novel C-4 Paclitaxel (Taxol) Analogues: Potent Antitumor Agents

Jianmei Wei, C. Fairchild, J. Kadow, 1996 .

Annual report, 1942-3.

W. Rose, 1943, The Eugenics review.

GROWTH UPON DIETS PRACTICALLY DEVOID OF ARGININE, WITH SOME OBSERVATIONS UPON THE RELATION OF GLUTAMIC AND ASPARTIC ACIDS TO NUTRITION

W. E. Bunney, W. Rose, 1928 .

Taxol-based combination chemotherapy and other in vivo preclinical antitumor studies.

W. Rose, 1993, Journal of the National Cancer Institute. Monographs.

In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.

W. Rose, G. Basler, 1990, In vivo.

Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogs.

W. Rose, W. T. Bradner, J. Schurig, 1982, Cancer treatment reports.

Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase.

J. Hunt, V. Manne, C. Ricca, 1999, Journal of medicinal chemistry.

STUDIES OF UREA EXCRETION. VII THE EFFECTS OF POSTURE AND EXERCISE ON UREA EXCRETION.

D. D. Van Slyke, W. Rose, A. Alving, 1932, The Journal of clinical investigation.

The amino acid requirements of man. XI. The threonine and methionine requirements.

M. J. Coon, W. Rose, H. B. Lockhart, 1955, The Journal of biological chemistry.

The amino acid requirements of man. XII. The leucine and isoleucine requirements.

M. J. Coon, W. Rose, C. Eades, 1955, The Journal of biological chemistry.

THE OXIDATION OF DISULFIDE ACIDS IN THE ANIMAL ORGANISM

W. Rose, B. D. Westerman, 1928 .

Tallysomycin S10b: Experimental antitumor activity and toxicity

W. Rose, W. T. Bradner, J. Schurig, 2004, Cancer Chemotherapy and Pharmacology.

Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents.

A. Sartorelli, W. Rose, P. Penketh, 1993, Journal of medicinal chemistry.

Synthesis and Evaluation of 1‐Acyl‐1,2‐bis(methylsulfonyl)‐2‐(2‐ chloroethyl)hydrazines as Antineoplastic Agents.

A. Sartorelli, W. Rose, P. Penketh, 1994 .

Evidence for the existence of an unidentified growth stimulant in proteins.

W. Rose, M. Womack, 1946 .

TRYPTOPHANE AND GROWTH II. GROWTH UPON A TRYPTOPHANE-DEFICIENT BASAL DIET SUPPLEMENTED WITH TRYPTOPHANE DERIVATIVES

C. P. Berg, W. Rose, C. Marvel, 1929 .

The amino acid requirements of man. VIII. The metabolic availability of the optical isomers of acetyltryptophan.

M. J. Coon, E. E. Howe, W. Rose, 1955, The Journal of biological chemistry.

FEEDING EXPERIMENTS WITH MIXTURES OF HIGHLY PURIFIED AMINO ACIDS VIII. ISOLATION AND IDENTIFICATION OF A NEW ESSENTIAL AMINO ACID

William C. Rose, W. Rose, Richard H. McCoy, 1935 .

MUCIC ACID AND INTERMEDIARY CARBOHYDRATE METABOLISM

W. Rose, 1911 .

The utilization of the optical isomers of phenylalanine, and the phenylalanine requirement for growth.

W. Rose, M. Womack, 1946, The Journal of biological chemistry.

THE AVAILABILITY OF TAURINE AS A SUPPLEMENTING AGENT IN DIETS DEFICIENT IN CYSTINE

W. Rose, B. Huddlestun, 1926 .

Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30

P. Trail, W. Rose, A. Casazza, 2004, Investigational New Drugs.